BD Biosciences Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 152

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $205M

BD Biosciences General Information

Description

Developer of an analytical flow cytometer designed to improve medical discovery, diagnostics and the delivery of care. The company's platform help enhance the safety and efficiency of clinicians' care delivery process, enabling scientists to study cells in more detail to better understand health and disease.

Contact Information

Formerly Known As
Accuri Cytometers
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 173 Parkland Plaza
  • Ann Arbor, MI 48103
  • United States
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Becton, Dickinson and Company
Vertical(s)
Corporate Office
  • 173 Parkland Plaza
  • Ann Arbor, MI 48103
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BD Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 07-Feb-2011 $205M Completed Generating Revenue
6. Later Stage VC (Series E) 12-Jul-2010 Completed Generating Revenue
5. Later Stage VC (Series D) 13-Jul-2009 Completed Startup
4. Later Stage VC (Series C) 08-Jul-2008 Completed Startup
3. Early Stage VC (Series B) 17-Apr-2007 Completed Startup
2. Accelerator/Incubator 01-Jan-2005 Completed Startup
1. Accelerator/Incubator 01-Jan-2005 Completed Startup
To view BD Biosciences’s complete valuation and funding history, request access »

BD Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 20,958,739 $0.000010 $0.02 $0.25 $0.25 1x $0.25 16.73%
Series A 15,471,493 $0.000010 $0.05 $0.39 $0.39 1x $0.31 15.54%
To view BD Biosciences’s complete cap table history, request access »

BD Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an analytical flow cytometer designed to improve medical discovery, diagnostics and the delivery of care. T
Discovery Tools (Healthcare)
Ann Arbor, MI
152 As of 2021

San Diego, CA
 

Saclay, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BD Biosciences Competitors (6)

One of BD Biosciences’s 6 competitors is BioLegend, a Formerly Accelerator/Incubator backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioLegend Formerly Accelerator/Incubator backed San Diego, CA
CIS Bio International Formerly PE-Backed Saclay, France
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
RayBiotech Venture Capital-Backed Peachtree Corners, GA
Miltenyi Biotec Private Debt Financed Bergisch Gladbach, Germany
To view BD Biosciences’s complete competitors history, request access »

BD Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BD Biosciences Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amherst Fund Venture Capital Minority
Arboretum Ventures Venture Capital Minority
Baird Capital PE/Buyout Minority
Credit Suisse Investment Bank Minority
Eight Roads Corporate Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

BD Biosciences Investments & Acquisitions (2)

BD Biosciences’s most recent deal was a Merger/Acquisition with Omega Biosystems. The deal was made on 27-Feb-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Omega Biosystems 27-Feb-2017 Merger/Acquisition Discovery Tools (Healthcare)
Adaptive Biotechnologies 06-May-2015 Later Stage VC Biotechnology
To view BD Biosciences’s complete investments and acquisitions history, request access »

BD Biosciences FAQs

  • When was BD Biosciences founded?

    BD Biosciences was founded in 2004.

  • Where is BD Biosciences headquartered?

    BD Biosciences is headquartered in Ann Arbor, MI.

  • What is the size of BD Biosciences?

    BD Biosciences has 152 total employees.

  • What industry is BD Biosciences in?

    BD Biosciences’s primary industry is Discovery Tools (Healthcare).

  • Is BD Biosciences a private or public company?

    BD Biosciences is a Private company.

  • What is the current valuation of BD Biosciences?

    The current valuation of BD Biosciences is .

  • What is BD Biosciences’s current revenue?

    The current revenue for BD Biosciences is .

  • How much funding has BD Biosciences raised over time?

    BD Biosciences has raised $28.2M.

  • Who are BD Biosciences’s investors?

    Amherst Fund, Arboretum Ventures, Baird Capital, Credit Suisse, and Eight Roads are 5 of 14 investors who have invested in BD Biosciences.

  • Who are BD Biosciences’s competitors?

    BioLegend, CIS Bio International, Abcam, RayBiotech, and Miltenyi Biotec are some of the 6 competitors of BD Biosciences.

  • When was BD Biosciences acquired?

    BD Biosciences was acquired on 07-Feb-2011.

  • Who acquired BD Biosciences?

    BD Biosciences was acquired by Becton, Dickinson and Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process